Medical Advocates
HCV Infection/Disease
  Extrahepatic Manifestations
 
General Reports 
Anemia 
Cancer
 Celiac Disease
Cardiovascular Disorders   
Cryoglobulinemia
Cholecystitis
Cutaneous Disorders
Erythropoiesis
Fatigue     		 Hearing Loss                         Thyroid Disorders    
Lymphatic Disease                 Sexual Dysfunction
Mental Health Disorders        Parkinson's Disease
Metabolic Disorders
Musculoskeletal Disorders
Nervous System Disorders
 Ophthalmologic Disorders
Oral Disorders
 Renal Disease 
Thrombocytopenia
HCV Main Page Main New/Newsworthy    Home Page    
Last Update:  March 28, 2018
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General/Miscellaneous Reports
 

         Journal Papers, Abstracts, and Commentaries

 
Skin manifestations in patients with hcv-related chronic liver disease.
 Satta R, Pes GM, Quarta Colosso BM, Dore MP.
J Eur Acad Dermatol Venereol. 2018 Feb 8.
 Abstract

Internal driving factors leading to extrahepatic manifestation of the hepatitis C virus infection.
Wu ZY, Li JR, Huang MH, et al\|||
 Int J Mol Med. 2017 Oct 5.
 Abstract

Treatment of Extrahepatic Manifestations of Hepatitis C Virus.
Degasperi E, Aghemo A, Colombo M.
 Clin Liver Dis. 2017 Aug;21(3):631-643
 Abstract

Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders).
Segna D, Dufour JF.
 Clin Liver Dis. 2017 Aug;21(3):60
Abstract

Extrahepatic Manifestations of Hepatitis C Virus After Liver Transplantation.
Wong RJ, Saab S, Ahmed A.
 Clin Liver Dis. 2017 Aug;21(3):595-606
 Abstract

The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.
 Mahale P, Engels EA, Li R, et al
Gut. 2017 Jun 20.
Abstract

International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement.
Zignego AL, Ramos-Casals M, Ferri C,  et al
Autoimmun Rev. 2017 Mar 7.
Abstract

Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection
Ramos-Casals M, Zignego AL, Ferri C, 1 et al
 J Hepatol. 2017 Feb 17.
 Abstract

FULL-TEXT ARTICLE
 Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
 Reid M, Ma Y, Scherzer R, Price JC, et al
 AIDS. 2017 Jan 28;31(3):385-393
 Paper

FULL-TEXT ARTICLE
 Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?
 Zachou K, Arvaniti P, Gatselis NK, et al
Mediterr J Hematol Infect Dis. 2017
Paper

Extrahepatic manifestations of chronic hepatitis C infection: a consecutive study in Brazilian patients.
 Tengan FM, Levy-Neto M, Miziara ID, et al
Braz J Infect Dis. 2016 Dec 6.
Abstract

Extrahepatic manifestations of HCV infection
 Husa P.
 Vnitr Lek. 2016 Fall;62(Suppl2):18-22. Czech.
Abstract

FULL-TEXT ARTICLE
 Systemic manifestations of hepatitis C infection.
 Tang L, Marcell L, Kottilil S.
Infect Agent Cancer. 2016 May 23;11:29
 Paper

Extrahepatic manifestations of chronic hepatitis C virus infection.
 Cacoub P, Comarmond C, Domont F,
Ther Adv Infect Dis. 2016 Feb;3(1):3-14.
 Abstract

Extrahepatic Manifestations of Hepatitis C Virus.
Viganò M, Colombo M.  
 Gastroenterol Clin North Am. 2015 Dec;44(4):775-91.
Abstract

Endocrine manifestations of chronic HCV infection.
Caviglia GP, Rosso C, Fagoonee S,  et al
Minerva Endocrinol. 2015 Sep 8.
 Abstract

Extra-hepatic Morbidity and Mortality of Chronic Hepatitis C.
 Negro F, Forton D, Craxì A, et al
Gastroenterology. 2015 Aug 25.
Abstract

Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM.
Sherman AC, Sherman KE.
Curr HIV/AIDS Rep. 2015 Jul 25
 Abstract

Extrahepatic manifestations in chronic hepatitis C virus carriers.
Rosenthal E, Cacoub P.
Lupus. 2015 Apr;24(4-5):469-
 Abstract

A case of multiple extrahepatic manifestations in a patient with untreated, chronic hepatitis C virus infection.
Meillier A, McGee J, Kartan S, Baskin S.
 Int J Infect Dis. 2013 Dec 5.
 Abstract

FULL-TEXT ARTICLE
 Measuring the response of extrahepatic symptoms and quality of life to antiviral treatment in patients with hepatitis C
 Isaacs D, Abdelaziz N, Keller M,  et al
Hepat Res Treat. 2013;2013:910519.
Paper

FULL-TEXT ARTICLE
 Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.
 Zampino R, Marrone A, Restivo L, et al
World J Hepatol. 2013 Oct 27;5(10):528-540.
 Paper

Hepatitis C Virus Infection Is Not An Independent Risk Factor For Obstructive Lung Disease.
Fischer Ii WA, Drummond MB, Merlo CA,  et al
COPD. 2013 Jul 17
 Abstract

Can brucellosis influence the course of chronic hepatitis C in dual infection?
Abou El Azm AR, Abou-Ali L, et al
Arch Virol. 2012 Nov 3.
 Abstract

FULL-TEXT ARTICLE
 Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.
 Himoto T, Masaki T.
 Clin Dev Immunol. 2012;2012:871401
 Paper

Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis
C virus infection after renal transplantation.
Cruzado JM, Bestard O, Grinyó JM
 Contrib Nephrol. 2012;176:108-16.
 Abstract

FULL-TEXT ARTICLE
 Association between Chronic Viral Hepatitis Infection and Breast Cancer Risk: a Nationwide
Population-based Case-control Study.
 Su FH, Chang SN, Chen PC, et al
BMC Cancer. 2011 Nov 24;11(1):495
 Paper

Outcomes After Lung Transplantation and Practices of Lung Transplant Programs in the
United States Regarding Hepatitis C Seropositive Recipients.
Fong TL, Cho YW, Hou L, et al
 Transplantation. 2011 Apr 21.
 Abstract

Sicca complex among Egyptian patients with chronic hepatitis C virus infection.
Nawito Z, Amin A, El-Fadl SA,et al
Clin Rheumatol. 2011 Apr 13.
 Abstract

Chronic Hepatitis C Virus Infection is Associated with More Severe Asthma.
 Nakashima T, Yokoyama A, Ohnishi H, et al
 Allergol Int. 2011 Mar 25.
Abstract

Necrolytic Acral Erythema as a Cutaneous Marker of Hepatitis C: Report of
Two Cases and Review.
Tabibian JH, Gerstenblith MR, Tedford RJ,  et al  
Dig Dis Sci. 2010 May 26
 Abstract

Comorbidities associated with the increasing burden of hepatitis C infection.
 Basseri B, Yamini D, Chee G, et al
Liver Int. 2010 Apr 8.
 Abstract

Extrahepatic manifestations associated with chronic hepatitis C infections in Poland.
Zarebska-Michaluk DA, Lebensztejn DM,  et al
Adv Med Sci. 2010 Apr 6:1-7.
 Abstract
 
 
       Conference Reports, Abstracts, and Posters
 
 
Comparison of extrahepatic HCV quasispecies evolution in blood peripheral mononuclear cells and plasma
H. Sahni, M. Winters, M. Holodniy
 (XX International AIDS Conference)
 Abstract
Anemia
 

         Journal Papers, Abstracts, and Commentaries

 
FULL-TEXT ARTICLE
Circulating autoantibodies to endogenous erythropoietin are associated with chronic hepatitis C virus infection-related anemia.
Tsiakalos A, Voumvas T, Psarris A, et al
 Hepatobiliary Pancreat Dis Int. 2017 Jun ;16(3):289-295.
 Paper

Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges, opportunities and recommendations.
 Romero-Gómez M, Berenguer M, Molina E, Calleja JL.  
J Hepatol. 2013 Jul 15.
 Abstract

Anemia Management in Patients with Chronic Viral Hepatitis C
Hynicka LM, Heil EL
 Ann Pharmacother. 2013 Feb 5.
 Abstract

HCV treatment-related anemia is associated with higher sustained virologic response rate.
 Sulkowski MS, Shiffman ML, Afdhal NH,  et al
Gastroenterology. 2010 Aug 16
 Abstract
 
Cancer
                          
         Journal Papers, Abstracts, and Commentaries
 
  Increased incidence of liver cancer after successful DAA treatment of chronic hepatitis C: Fact or fiction?
Alberti A, Piovesan S
 Liver Int. 2017 Jun;37(6):802-808.
Abstract

Increased incidence of cancer observed in HIV/HCV-coinfected patients versus HIV-monoinfected, 1993-2014.
Meijide H, Pértega S, Rodríguez-Osorio I, et al
AIDS. 2017 Mar 21.
 Abstract
Celiac Disease
                          
         Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Onset of Celiac Disease after Treatment of Chronic Hepatitis C with Interferon Based Triple Therapy.
Singh A, Zaeri N, Ho IK.
 Case Reports Hepatol. 2015;2015:763497.
 Paper
Cholecystitis
                          
         Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Acute acalculous cholecystitis caused by Hepatitis C: A rare case report.
 Omar A, Osman M, Bonnet G, Ghamri N.
Int J Surg Case Rep. 2015 Dec 17;19:78-81.
Paper
Cryoglobulinemia
       
       Journal Papers, Abstracts, and Commentaries
 
 
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia: a multicentre open-label study.
 Mazzaro C, Dal Maso L, Quartuccio L, et al  
Clin Exp Rheumatol. 2018 Feb 1
 Abstract

MPGN and mixed cryoglobulinemia in a patient with hepatitis C - new treatment implications and renal outcomes.
 Palombo SB, Wendel EC, Kidd LR, et al
Clin Nephrol Case Stud. 2017 Oct 23;5:66-69i
 Abstract

Mixed cryoglobulinemia: an important but frequently unrecognized and underestimated HCV-related condition in the real life practice.
Kondili LA, Vella S, Zignego AL; PITER collaborating Group
 Liver Int. 2017 Jun 9.
 Abstract

FULL-TEXT ARTICLE
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience.
Lauletta G, Russi S, Pavone F,  et al
 Arthritis Res Ther. 2017 Apr 8;19(1):74
 Paper

FULL-TEXT ARTICLE
Analysis, detection and quantitation of mixed cryoglobulins in HCV infection: brief review and case examples.
 Voma CB, Levinson SS.
Clin Chem Lab Med. 2016 Dec 1;54(12):1853
 Paper

Prospective Study of Guideline-Tailored Therapy with Direct-Acting Antivirals for Hepatitis C Virus-Associated Mixed Cryoglobulinemia.
 Gragnani L, Visentini M, Fognani E, et al
Hepatology. 2016 Aug 2.
Abstract

Treatment of Hepatitis C Virus-Associated Mixed Cryoglobulinemia with Sofosbuvir-Based Direct-Acting Antiviral Agents.
 Sise ME, Bloom AK, Wisocky J, et al
Hepatology. 2015 Oct 17.
 Abstract

Low Vitamin D Levels Are Associated with the Presence of Serum Cryoglobulins in Patients with Chronic HCV Infection.
 Gentile I, Scarano F, Celotti A,  et al
In Vivo. 2015 05-06;29(3):399-404.
 Abstract

Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study.
 Lauletta G, Russi S, Conteduca V,  et al
Medicine (Baltimore). 2013 Aug 26.
 Abstract

Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.
Retamozo S, Díaz-Lagares C, Bosch X,  et al
Medicine (Baltimore). 2013 Aug 22.
 Abstract

Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia.
Charles ED, Orloff MI, Nishiuchi E,  et al
Arthritis Rheum. 2013 Jun 10.
 Abstract

FULL-TEXT ARTICLE
 Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia.
 Fognani E, Giannini C, Piluso A, Gragnani L,  et al
PLoS One. 2013 May 1;8(5):e62965.
Paper

Antiviral therapy of symptomatic HCV-mixed 
cryoglobulinemia after liver transplant: Case 
report and literature review.
 Francesca Donato M, Banfi G,  et al
 Int J Artif Organs. 2013 Feb 28:0..
 Abstract

Antiviral Therapy for HCV-Associated Cryoglobulinemic Glomerulonephritis: Case Report and Review of the Literature.
 Fabrizi F, Fogazzi GB, Cresseri D, et al
Kidney Blood Press Res. 2013 Jan 8;35(6):687-693.
 Abstract

FULL-TEXT ARTICLE
 HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A
Concurrent Pathogenetic Role.
Sautto G, Mancini N, Solforosi L, et al
Clin Dev Immunol. 2012;2012:705013
 Paper

Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis.
Foschi FG, Dall'aglio AC, Lanzi A,et al
World J Gastrointest Pharmacol Ther. 2010 Apr 6;1(2):72-4.
 Abstract

Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia:
Role of polymorphic variants of BAFF promoter and Fcγ receptors.
Gragnani L, Piluso A, Giannini C, et al
Arthritis Rheum. 2011 May;63(5):1446-51.
 Abstract

HCV-related cryoglobulinemic syndrome beginning as isolated gynaecologic vasculitis.
Quartuccio L, Maset M, Di Loreto C, De Vita S.
Clin Exp Rheumatol. 2011 Feb 2. .
 Abstract

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis
C virus-infected patients.
 Pietrogrande M, Devita S, Zignego A,  et al
 Autoimmun Rev. 2011 Feb 14.|
 Abstract

Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with
double-filtration plasmapheresis and interferon combination therapy.
 Namba T, Shiba R, Yamamoto T, et al
Clin Exp Nephrol. 2010 May 14.
Abstract

Rituximab plus Peg-Interferon {alpha} /ribavirin compared to Peg- Interferon
{alpha} /ribavirin in Hepatitis C related mixed cryoglobulinemia.
Saadoun D, Resche Rigon M, et al
Blood. 2010 May
 Abstract

Causes and Predictive Factors of Mortality in a Cohort of Patients with Hepatitis C Virus-related
Cryoglobulinemic Vasculitis Treated with Antiviral Therapy.
Landau DA, Scerra S, Sene D, et al
J Rheumatol. 2010 Jan 28
 Abstract

Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of
complicated HCV-related cryoglobulinemia.
Stefanutti C, Vivenzio A, Di Giacomo S,et al
J Clin Apher. 2009 Nov 19.
 Abstract

Current therapeutic strategies for HCV-associated cryoglobulinemia.
 Iannuzzella F, Garini G
Reumatismo. 2008;60(3):163-173.
 Abstract
 
FULL-TEXT PDF ARTICLE
 Cryoglobulinaemia in hepatitis C-positive patients in Iran.
 Owlia MB, Sami R, Akhondi M, Salimzadeh A. 
Singapore Med J. 2007 Dec;48(12):1136-9
Paper
 
Symptomatic and Virological Response to Antiviral Therapy in Hepatitis C Associated with
Extrahepatic Complications of Cryoglobulimia.
 Joshi S, Kuczynski M, Heathcote EJ.
Dig Dis Sci. 2007 Apr 6;
 Abstract
 
Central nervous system involvement in HCV-related mixed cryoglobulinemia.
Cappellari A, Origgi L, Spina MF, et al
Electromyogr Clin Neurophysiol. 2006 May-Jun;46(3):149-58
 Abstract
 
Polyarteritis nodosa and cryoglobulinemic glomerulonephritis related to chronic hepatitis C.
 Canada R, Chaudry S, Gaber L, et al  
Am J Med Sci. 2006 Jun;331(6):329-33.
 Abstract
 
Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and
without human immunodeficiency virus (HIV) coinfection.
 Dezzutti CS, Astemborski J, Thomas DL, et al
J Clin Virol. 2004 Nov;31(3):210-4.
 Abstract
 
Treatment of chronic hepatitis C infection with cryoglobulinemia.
 Della Rossa A, Tavoni A, Baldini C.
 Curr Opin Rheumatol 2002 May;14(3):231-7
 Abstract
 
Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations.
 Leone N, Pellicano R, Ariata Maiocco I, et al
 J Med Virol 2002 Feb;66(2):200-3
 Abstract
 
Cutaneous Disorders
 

          Journal Papers, Abstracts, and Commentaries             

  Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.
Wiznia LE, Laird ME, Franks AG Jr.
 J Eur Acad Dermatol Venereol. 2017 Mar 2.
Abstract

FULL-TEXT ARTICLE
 Cutaneous manifestations of hepatitis C in the era of new antiviral agents.
 Garcovich S, Garcovich M, Capizzi R,  et al 
World J Hepatol. 2015 Nov 28;7(27):2740-2748
 Paper

Hepatitis C infection in Italian psoriatic patients: prevalence and correlation with patient age and psoriasis severity.
 Brazzelli V, Carugno A, Alborghetti A,
 J Eur Acad Dermatol Venereol. 2011 Dec 6
 Abstract
Digestive System Disorders
                          
         Journal Papers, Abstracts, and Commentaries
 
 
Chronic hepatitis virus infection increases the risk of pancreatic cancer: a meta-analysis.
 Xing S, Li ZW, Tian YF,. et al
Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):575-83.
 Abstract

Oral conditions associated with Hepatitis C virus infection.
 Alavian SM, Mahboobi N, Mahboobi N, Karayiannis P.
Saudi J Gastroenterol. 2013 Nov-Dec;19(6):245
Abstract

Gastrointestinal Histoplasmosis in a Hepatitis C-Infected Individual.
Rodriguez-Waitkus PM, Bayat V,  et al
 Mycopathologia. 2013 Jun 13.
 Abstract

Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: A systematic review and meta-analysis.
Fiorino S, Chili E, Bacchi-Reggiani L, Masetti M,  et al
Pancreatology. 2013 Mar-Apr;13(2):147-60.
Abstract

FULL-TEXT ARTICLE
 Treatment for Eradication of Helicobacter pylori Infection among Chronic Hepatitis C Patients.
Furusyo N, Walaa AH, Eiraku K, et al
Gut Liver. 2011 Dec;5(4):447-53
 Paper

Review article: prevention and management of hepatitis B and C infection in patients with
inflammatory bowel disease.
 Gisbert JP, Chaparro M, Esteve M.
Aliment Pharmacol Ther. 2011 Mar;33(6):619-33.
 Abstract

Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related
systemic vasculitis: a case-control study from a single-centre cohort of 163 patients.
Terrier B, Saadoun D, Sène D,  et al
Gut. 2010 Sep 14.
 Abstract

Coeliac disease in chronic hepatitis C: a French multicentre prospective study.
 Thevenot T, Denis J, Jouannaud V,et al  
Aliment Pharmacol Ther. 2007 Nov;26(9):1209-1216.
 Abstract
Erythropoiesis
                          
         Journal Papers, Abstracts, and Commentaries
 
  Disease severity and erythropoiesis in chronic hepatitis C.
 Huang CF, Huang CI, Yeh ML,  et al
J Gastroenterol Hepatol. 2016 Sep 16.
 Abstract
Fatigue
                          
         Journal Papers, Abstracts, and Commentaries
 
  Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection.
Golabi P, Sayiner M, Bush H,
Clin Liver Dis. 2017 Aug;21(3):565-578.
Abstract

Depression and Fatigue in Chronic Hepatitis C Patients with and Without HIV Co-Infection.
Tavakkoli M, Ferrando SJ, Rabkin J,  et al
Psychosomatics. 2013 Jun 4.
Abstract

Fatigue in patients with chronic hepatitis C.
 Poynard T, Cacoub P, Ratziu V, et al
J  Viral Hepat 2002 Jul;9(4):295-303
 Abstract

  
Hearing Loss
                          
         Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection
 Chen HC, Chung CH, Wang CH, et al
PLoS One. 2017 Apr 6;12(4):e0175266.
Paper
Lichen Planus
                          
         Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C virus and lichen planus.
Nagao Y, Sata M.   
 J Gastroenterol Hepatol. 2004 Oct;19(10):1101-1113.
 Abstract
Lymphatic Disease
                          
         Journal Papers, Abstracts, and Commentaries
 
 
FULL TEXT ARTICLE
 Hepatitis C virus-related lymphoproliferative disorders: An overview.
Zignego AL, Giannini C, Ferri C.
 World J Gastroenterol. 2007 May 7;13(17):2467-78.
 Paper

Hepatitis C virus (HCV) I hepatitis C virus (HCV) infection and lymphoproliferative
disorders.
 Libra M, Gasparotto D, Gloghini A, Navolanic PM, et al
Front Biosci. 2005 Sep 1;10:2460-71
 Abstract
Mental Health Disorders
                          
         Journal Papers, Abstracts, and Commentaries
 
 
Incidence and predictors of mental health disorder diagnoses among people who inject drugs in a Canadian setting.
Reddon H, Pettes T, Wood E, et al  
Drug Alcohol Rev. 2017 Nov 22
 Abstract

Hepatitis C virus infection, and neurological and psychiatric disorders - A review.
 Yarlott L, Heald E, Forton D.
J Adv Res. 2017 Mar;8(2):139-148.
Abstract

Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis.
Fialho R, Pereira M, Rusted J, Whale R.
Psychol Health Med. 2017 Jan 19:1-16.
Abstract

Collaborative Care for Depression in Chronic Hepatitis C Clinics.
 Kanwal F, Pyne JM, Tavakoli-Tabasi S, et al
Psychiatr Serv. 2016 Jul 1:appips201400474.
Abstract

Depression and Immunity: the HCV model.
Apicella E.
Psychiatr Danub. 2014 Nov;26 Suppl 1:132-7.
 Abstract

Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for Hepatitis C infection.
 Mahajan S, Avasthi A, Grover S, Chawla YK
 J Psychosom Res. 2014 Aug;77(2):109-115
 Abstract

Depression and Fatigue in Chronic Hepatitis C Patients with and Without HIV Co-Infection.
Tavakkoli M, Ferrando SJ, Rabkin J,  et al
Psychosomatics. 2013 Jun 4.
 Abstract

Managing psychiatric side effects of antiviral therapy in chronic hepatitis C
Schäfer A, Scheurlen M, Kraus MR.
Z Gastroenterol. 2012 Oct;50(10):1108-13..
 Abstract

Hepatitis C infection, antiviral treatment and Mental Health: A European Expert Consensus Statement.
Schaefer M, Capuron L, Friebe A,  et al
J Hepatol. 2012 Aug .
 Abstract

Time to Rethink Antiviral Treatment for Hepatitis C in Patients with Coexisting Mental Health/Substance
Abuse Issues.
Bonner JE, Barritt AS 4th, Fried MW, Evon DM.
Dig Dis Sci. 2012 Apr 7
 Abstract

Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II:
do somatic symptoms compromise validity?
Patterson AL, Morasco BJ, Fuller BE, et al
 Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):354-62
 Abstract

Somatic symptoms and the association between hepatitis C infection and depression in
HIV-infected patients.
Yoon JC, Crane PK, Ciechanowski PS,  et al|
AIDS Care. 2011 May 11:1-11.
 Abstract

Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy:
a double-blind, placebo-controlled trial.
 Morasco BJ, Loftis JM, Indest DW,  et  al
Psychosomatics. 2010 Sep;51(5):401-8.
 Abstract
Musculoskeletal Disorders
                          
         Journal Papers, Abstracts, and Commentaries
 
 
Retrospective Study of Patients on Etanercept Therapy for Rheumatic Diseases in Patients With Chronic Hepatitis C Virus.
Gandhi NP, Manadan AM, Block JA.
 J Clin Rheumatol. 2017 Jul 11
 Abstract

The impact of hepatitis C virus infection on 90-day outcomes following major orthopaedic surgery: a propensity-matched analysis.
 Chowdhury R, Chaudhary MA, Sturgeon DJ,  et al
Arch Orthop Trauma Surg. 2017 Jul 3
 Abstract

FULL-TEXT ARTICLE
Rheumatologic Manifestations of Hepatitis C Virus Infection.
Cacoub P, Comarmond C, Desbois AC, Saadoun D.
 Clin Liver Dis. 2017 Aug;21(3):455-464.
 Paper

FULL-TEXT ARTICLE
Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis.
Siloşi I, Boldeanu L, Biciuşcă V,  et al
 Int J Mol Sci. 2017 Jun 19;18(6)
 Paper

A case of hepatitis C-associated osteosclerosis: accelerated bone turnover controlled by pulse steroid therapy.
Miyamura N, Nishida S, Itasaka M,
Endocrinol Diabetes Metab Case Rep. 2016;2016. pii: 16-0097..
 Abstract

FULL-TEXT ARTICLE
Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.
Palazzi C, D'Amico E, D'Angelo S, Gilio M, Olivieri I.
 World J Gastroenterol. 2016 Jan 28;22(4):1405
 Paper

Relation Between Hepatitis C Virus Exposure and Risk of Osteoporosis: A Nationwide Population-Based Study.
Chen CH, Lin CL, Kao CH.
Medicine (Baltimore). 2015 Nov;94(47):e2086
 Abstract

Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease.
 Bedimo R, Cutrell J, Zhang S, et al
AIDS. 2015 Nov 10
 Abstract

HCV-related rheumatic manifestations and therapeutic strategies.
Sebastiani M, Giuggioli D, Colaci M,  et al
 Curr Drug Targets. 2015 Sep 6.
 Abstract

Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Lin KM, Cheng TT, Lin JC, Chen CJ.
 Clin Rheumatol. 2015 May 5.
 Abstract

FULL-TEXT ARTICLE
 Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and  monoinfection.
 Ogdie A, Pang WG, Forde KA,  et al
BMC Musculoskelet Disord. 2015 Apr 19;16(1):93.
 Paper

Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis.
 Dong HV, Cortés YI, Shiau S, Yin MT.
AIDS. 2014 Jun 28
 Abstract

An uncommon cause of acquired osteosclerosis in adults: hepatitis C-associated osteosclerosis.
Epperla N, McKiernan FE.
Skeletal Radiol. 2014 Apr 10
 Abstract

Acute myelitis associated with HCV infection.
 Suzuki K, Takao M, Katayama Y, Mihara B.
BMJ Case Rep. 2013 Jun 13;2013..
 Abstract

Association Between Chronic Hepatitis C Virus Infection and Bone Mineral Density.
Lin JC, Hsieh TY, Wu CC,  et al
 Calcif Tissue Int. 2012 Oct 5.
 Abstract

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/HIV Coinfection.
Lo Re V 3rd, Volk J, Newcomb CW,  et al
 Hepatology. 2012 May 22.
Abstract

Current treatment of hepatitis C-associated rheumatic diseases.
 Ferri C, Sebastiani M, Antonelli A, et alA
rthritis Res Ther. 2012 Jun 25;14(3):215.
 Abstract
Nervous System Disorders
                          
         Journal Papers, Abstracts, and Commentaries
 
 

Neurologic Manifestations of Hepatitis C Virus Infection.
 Iriana S, Curry MP, Afdhal NH.
Clin Liver Dis. 2017 Aug;21(3):535-542
 Abstract

Measuring and managing cognitive impairment in HIV.
Nightingale S, Winston A.
AIDS. 2017 Jun 1;31 Suppl 2:S165-S172.
Abstract

Hepatitis C virus infection, and neurological and psychiatric disorders - A review.
 Yarlott L, Heald E, Forton D.
J Adv Res. 2017 Mar;8(2):139-148.
Abstract

FULL-TEXT ARTICLE
 Hepatitis C virus and neurological damage.
 Mathew S, Faheem M, Ibrahim SM,  et al
World J Hepatol. 2016 Apr 28;8(12):545-56
 Paper

FULL-TEXT ARTICLE
 Cognitive dysfunction and hepatitis C virus infection.
 Solinas A, Piras MR, Deplano A.
World J Hepatol. 2015 May 8;7(7):922-5.
 Paper

Neuropathies in hepatitis C-related liver cirrhosis.
Abdelkader NA, Zaky DZ, Afifi H, et al
Indian J Gastroenterol. 2014 Oct 12.
 Abstract

Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment.
Gupta S, Iudicello JE, Shi C,  et al
Drug Alcohol Depend. 2014 Apr 1;137:29-35.
 Abstract

Hepatitis C viral infection and the risk of dementia.
 Chiu WC, Tsan YT, Tsai SL,  et al
Eur J Neurol. 2013 Dec 7
 Abstract

Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.
 Sakamoto M, Woods SP, Kolessar M, et al
J Neurovirol. 2013 Sep 10.
Abstract

Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J, Zimny A, Knysz B, et al
J Hepatol. 2013 May 13.
Abstract

Dorsal root ganglionopathy in a hepatitis C patient: a case report  .
Basavaraju N, Ahmad M, Slattery E
 Ann Hepatol. 2012 Nov;11(6):958-60.
 Abstract

FULL-TEXT ARTICLE
 HCV-Related Nervous System Disorders.
Monaco S, Ferrari S, Gajofatto A,  et al
 Clin Dev Immunol. 2012;2012:236148
 Abstract

Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection
in Patients on Suppressive Antiretroviral Therapy.
Yilmaz A, Verhofstede C, Davolio A, et al
J Acquir Immune Defic Syndr. 2010 Sep 16
 Abstract

Demyelinating neuropathy in patients with hepatitis C virus infection.
 Chin RL, Sander HW, Brannagan TH 3rd, et al
J Clin Neuromuscul Dis. 2010 Jun;11(4):209-12.
 Abstract

Impaired cognitive function in hepatitis C - a review.
 Renvillard SG, Leutscher PD, Hjerrild S, Videbech P.
 Ugeskr Laeger. 2010 Feb 1;172(5):372-376
 Abstract
Ophthalmologic Disorders
                          
         Journal Papers, Abstracts, and Commentaries
 
  Prevalence of photosensitivity in chronic hepatitis C virus patients and its relation to serum and urinary porphyrins.
Esmat S, Elgendy D, Ali M, Esmat S, et al
Liver Int. 2014 Feb 28.
Abstract

FULL-TEXT ARTICLE
 Ophthalmologic complications of antiviral therapy in hepatitis C treatment.
 O'Day R, Gillies MC, Ahlenstiel G. et al
World J Gastroenterol. 2013 Dec 7;19(45):8227-8237.
 Paper

  
Oral Disorders
                          
         Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Oral manifestations of hepatitis C virus infection.
 Carrozzo M, Scally K.
World J Gastroenterol. 2014 Jun 28;20(24):7534-7543
 Paper
 
Renal Disease
 

          Journal Papers, Abstracts, and Commentaries

 
New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat.
Sawinski D, Forde KA, Wyatt CM.
 Am J Kidney Dis. 2018 Mar 23
 Abstract

Are we underestimating the quality of aviremic Hepatitis C positive kidneys? Time to reconsider.
Sibulesky L, Kling CE, Blosser C et al
 Am J Transplant. 2018 Feb 16
 Abstract

Long term Outcomes and Transmission Rates in Hepatitis C Virus Positive Donor to Hepatitis C Virus Negative Kidney Transplant Recipients: Analysis of United States National Data.
 Gupta G, Kang L, Yu JW, Limkemann AJ, et al
Clin Transplant. 2017 Jul 16.
Abstract

A case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressant.
 Obata F, Murakami T, Miyagi J,  et al 
CEN Case Rep. 2017 May;6(1):55-60.
 Abstract

Treating Hepatitis C in Patients with Renal Failure.
 Lens S, Rodriguez-Tajes S, Llovet LP, et al
Dig Dis. 2017;35(4):339-346.
Abstract

Hepatitis C Viral Load, Genotype, and Increased Risk of Developing End-stage Renal Disease: REVEAL-HCV Study.
Lai TS, Lee MH, Yang HI, et al
Hepatology. 2017 Apr 2
 Abstract

Experience with direct acting anti-viral agents for treating hepatitis C virus infection in renal transplant recipients.
 Goel A, Bhadauria DS, Kaul A, et al
Indian J Gastroenterol. 2017 Mar 27.
Abstract

New-onset hepatitis C virus-associated glomerulonephritis following sustained virologic response with direct-acting antiviral therapy
.
Ghosn M, Palmer MB, Najem CE,et al
 Clin Nephrol. 2017 Mar 23.
Abstract

Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care
Utilization and Cost.
 Solid  CA, Peter SA, Natwick T, et al
Nephron. 2017 Feb 18.
Abstract

Hepatitis C and kidney disease: A narrative review
 Barsoum RS, William EA, Khalil SS.
J  Adv Res. 2017 Mar;8(2):113-130.
Abstract
FULL-TEXT ARTICLE
Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective.
Jadoul M, Martin P.
 Blood Purif. 2017 Jan 24;43(1-3):206
Paper

Chronic Hepatitis C and Chronic Kidney disease: Advances, Limitations and Unchartered Territories.
 Mendizabal M, Reddy KR.
 J Viral Hepat. 2017 Jan 20. 
Abstract

A systematic review and meta-analysis: Does hepatitis C virus infection predispose to the development of chronic kidney disease ?
Li M, Wang P, Yang C, et al
 Oncotarget. 2016 Oct 25
 Abstract

Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
 Cacoub P, Desbois AC, Isnard-Bagnis C, ,et al
 J Hepatol. 2016 Oct;65(1 Suppl):S82-94
 Abstract

New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
 Fabrizi F, Martin P, Messa P.
Kidney Int. 2016 May;89(5):988-94.
Abstract

An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO Guidelines
Pol S, Jadoul M, Vallet-Pichard A.
 Nephrol Dial Transplant. 2016 Mar 22
 Abstract

HCV and the kidney.
Corouge M, Vallet-Pichard A, Pol S.
 Liver Int. 2016 Jan;36 Suppl 1:28-33.
Abstract

Renal function is impaired in normotensive chronic HCV patients: role of insulin resistance.
Sciacqua A, Perticone M, Tassone EJ,  et al
 Intern Emerg Med. 2015 Nov 23.
Abstract

Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Fabrizi F, Verdesca S, Messa P, Martin P.
Dig Dis Sci. 2015 Jul 21.
Abstract

Dialysis-requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysis.
 Nadkarni GN, Patel A, Simoes PK, et al
J Viral Hepat. 2015 Jul 20.
 Abstract

Acute Kidney Dysfunction in Patients with Chronic Hepatitis C Virus Infection: Analysis of Viral and Non-viral Factors.
Satapathy SK, Lingisetty CS, Williams SE.
J Clin Exp Hepatol. 2014 Mar;4(1):8-13..
 Abstract

FULL-TEXT ARTICLE
 Management of hepatitis C in patients with chronic kidney disease.
Carvalho-Filho RJ, Feldner AC, et al 
World J Gastroenterol. 2015 Jan 14;21(2):408-422.
Paper

Novel evidence on hepatitis C virus-associated glomerular disease.
 Fabrizi F, Messa P, Martin P.
Kidney Int. 2014 Sep;86(3):466-9
 Abstract

FULL-TEXT ARTICLE
 Hepatitis C virus associated glomerulopathies.
 Ozkok A, Yildiz A.
World J Gastroenterol. 2014 Jun 28
 Paper

Acute hepatitis C infection in a renal transplant recipient: primacy of the liver or kidney?
 Althaf MM, Abdelsalam MS, Rashwan M, Nadri Q.
BMJ Case Rep. 2014 Jun 6;2014..
 Abstract

Hepatitis C virus infection in end stage renal disease and kidney transplantation.
Burra P, Rodríguez-Castro KI,  et al
 Transpl Int. 2014 May 23.
Abstract

Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after living donor liver transplantation:
significance of renal biopsy.
 Fujinaga K, Usui M, Yamamoto N, et al
 Transplant Proc. 2014 Apr;46(3):804-10.
 Abstract

Hepatitis C virus core antigen testing in liver and kidney transplant recipients.
 Heidrich B, Pischke S, Helfritz FA, et al
J Viral Hepat. 2013 Nov 19.
 Abstract

Outcomes following renal transplantation in patients with chronic hepatitis C based on severity of fibrosis on pre-transplant liver biopsy.
Dbouk N, Parekh S.
 Saudi J Kidney Dis Transpl. 2013 July-August;24(4):682-687..
 Abstract

Hepatitis C virus-associated glomerulonephritis.
Tang SC, Lai KN.
 Contrib Nephrol. 2013;181:194-206
 Abstract

Hepatitis C virus and kidney disease.
Kamar N, Alric L, Izopet J, Rostaing L.
 Clin Res Hepatol Gastroenterol. 2013 Mar 20.
 Abstract

The evidence-based epidemiology of HCV-associated kidney disease.
Fabrizi F, Dixit V, Martin P, Messa P.
 Int J Artif Organs. 2012 Aug 8:0.
 Abstract

FULL-TEXT ARTICLE
Inauspicious contribution of hepatitis C virus and diabetes mellitus targeting kidneys: an update.
 Alavian SM, Taheri S.
Iran J Kidney Dis. 2012 Jul;6(4):236-54..
 Paper

Experience of fibrosing cholestatic hepatitis with hepatitis C virus in kidney transplant recipients.
Siddiqui AR, Abbas Z, Luck NH, et al
Transplant Proc. 2012 Apr;44(3):721-4..
 Abstract

Selection and management of hepatitis C virus-infected patients for the kidney transplant
waiting list.
Roth D, Bloom R.
 Contrib Nephrol. 2012;176:66-76.
 Abstract

Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.
Manuel O, Baid-Agrawal S, Moradpour D, Pascual M.
Contrib Nephrol. 2012;176:97-107
 Abstract

Treatment of Hepatitis C-Mediated Glomerular Disease.
 Sandri AM, Elewa U, Poterucha JJ, Fervenza FC.
 Nephron Clin Pract. 2011 Jul 8;119(2):c121-c130.
 Abstract

The influence of hepatitis B and C virus infections on patient and allograft outcomes in
kidney transplantation.
Uyar M, Sahin S, Dheir H, Gurkan A
Transplant Proc. 2011 Apr;43(3):850-2.
 Abstract

Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection:
a cure and so much more.
 Pearlman BL, Traub N
 Clin Infect Dis. 2011 Apr;52(7):889-900
 Abstract

Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection:
a nationwide register-based cohort study in Sweden.
Hofmann JN, Törner A, Chow WH,  et al
Eur J Cancer Prev. 2011 Mar 6.
 Abstract

Treatment of HCV infected patients and renal disease."
Kershenobich D.
 Ann Hepatol. 2010;9 Suppl:103-6.
 Abstract

Kidney Grafts From HCV-Positive Donors: Advantages and Disadvantages.
 Maluf DG, Archer KJ, Mas VR.
Transplant Proc. 2010 Sep;42(7):2436-46.
 Abstract

A hepatitis C-positive patient with new onset of nephrotic syndrome and systemic
amyloidosis secondary to common variable immunodeficiency.
 Turkmen K, Anil M, Solak Y,  et al
 Ann Saudi Med. 2010 Aug 10.
 Abstract
 
Sexual Dysfunction
 

          Journal Papers, Abstracts, and Commentaries

  Erectile dysfunction in patients with chronic hepatitis C virus infection.
Hunter SS, Gadallah A, Azawi MK, Doss W.
Arab J Gastroenterol. 2014 Mar;15(1):16-20
 Abstract
Thrombocytopenia
 

          Journal Papers, Abstracts, and Commentaries

 
Late-Onset Immune Thrombocytopenic Purpura After Withdrawal of Interferon Treatment for Chronic Hepatitis C Infection: A Case Report.
 Hsiao CH, Tseng KC, Tseng CW, Tung CH.
Medicine (Baltimore). 2015 Aug;94(34):e1296.
 Abstract

Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five European countries.
 Rizzetto M, Grotzinger K, Theodore D,  et al
 J Viral Hepat. 2014 Apr 3.
Abstract

Thrombocytopenia in chronic hepatitis C.
Olariu M, Olariu C, Olteanu D.
J Gastrointestin Liver Dis. 2010 Dec;19(4):381-5
 Abstract
Thyroid Disorders
 

          Journal Papers, Abstracts, and Commentaries

 
FULL-TEXT ARTICLE
 Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment.
 Pastore F, Martocchia A, Stefanelli M, et al
World J Hepatol. 2016 Jan 18;8(2):83-91.
Paper

Frequency of thyroid disorders during interferon and ribavirin therapy in chronic hepatitis C infection.
Masood N, Ghori R, Memon A, et al
J Coll Physicians Surg Pak. 2008 Jun;18(6):347-51.
 Abstract
Parkinson's Disease
 

          Journal Papers, Abstracts, and Commentaries

  Evidence for association between hepatitis C virus and Parkinson's disease.
Abushouk AI, El-Husseny MWA, Magdy M,
 Neurol Sci. 2017 Aug 5.
 Abstract

 
HCV Main Page Main New/Newsworthy    Home Page    

Extrahepatic Manifestations